What is the management plan for acute ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Ischemic Stroke

Administer IV alteplase (0.9 mg/kg, maximum 90 mg) to eligible patients within 3 hours of symptom onset, with a target door-to-needle time under 60 minutes, and consider endovascular thrombectomy for large vessel occlusions within 6-24 hours based on imaging selection. 1, 2, 3

Pre-Hospital Recognition and Transport

  • EMS should use FAST (Face, Arms, Speech, Time) screening tools to rapidly identify stroke patients, as even a single abnormality has 72% probability of stroke 2, 3
  • Pre-notify the receiving hospital immediately to activate stroke protocols and prepare the stroke team, imaging, and necessary resources before patient arrival 2, 3
  • Document the exact time the patient was last known to be normal (last known well time), as this determines treatment eligibility, not when symptoms were discovered 1, 3
  • Transport directly to comprehensive stroke centers capable of endovascular therapy when large vessel occlusion is suspected, rather than routing through primary stroke centers ("mothership" approach preferred over "drip-and-ship" when feasible) 1

Emergency Department Assessment (Target: Door-to-Imaging <25 minutes)

  • Perform immediate non-contrast CT scan to rule out hemorrhage and identify early infarction signs 1, 2, 3
  • Complete CT angiography immediately to identify large vessel occlusions and their location 2, 3
  • Assess NIHSS score during parallel processing while imaging is being obtained 1
  • Obtain essential labs: CBC, PT/INR, aPTT, glucose, electrolytes, renal function (but do not delay treatment waiting for results unless anticoagulation use is suspected) 1, 2

IV Alteplase Administration (0-3 Hours Window)

Inclusion criteria 1:

  • Clearly defined symptom onset within 3 hours
  • Measurable neurologic deficit on NIHSS
  • Age ≥18 years
  • CT scan showing no hemorrhage

Critical exclusion criteria 1:

  • Blood pressure >185/110 mmHg (must lower before treatment)
  • Platelet count <100,000
  • INR >1.6 or PT >15 seconds
  • Glucose <50 or >400 mg/dL
  • Prior stroke or serious head injury within 3 months
  • Major surgery within 14 days
  • History of intracranial hemorrhage
  • Rapidly improving or minor symptoms

Dosing protocol 1, 3:

  • 0.9 mg/kg (maximum 90 mg total)
  • Give 10% as IV bolus over 1 minute
  • Infuse remaining 90% over 60 minutes
  • Administer directly in CT room after excluding hemorrhage to minimize door-to-needle time 1

Extended Window Alteplase (3-4.5 Hours)

Additional exclusion criteria beyond standard 0-3 hour criteria 1:

  • Age >80 years
  • NIHSS >25
  • Combination of prior stroke AND diabetes
  • ANY oral anticoagulant use (regardless of INR)

Note: The 3-4.5 hour window shows more modest benefits with higher comorbidity patients excluded 1. For wake-up strokes with unknown onset time, alteplase may be considered if DWI/FLAIR mismatch is present on MRI 1.

Blood Pressure Management

Before alteplase administration 1, 3:

  • Must achieve BP <185/110 mmHg before giving alteplase
  • Use labetalol, nicardipine, or clevidipine to lower BP if needed

During and after alteplase (first 24 hours) 1, 3:

  • Maintain BP ≤180/105 mmHg
  • Monitor BP every 15 minutes during infusion and for 2 hours after
  • Then every 30 minutes for 6 hours
  • Then hourly until 24 hours

For patients NOT receiving alteplase 2:

  • Avoid treating hypertension unless systolic BP >220 mmHg or diastolic BP >120 mmHg
  • Permissive hypertension supports cerebral perfusion in acute phase

Endovascular Thrombectomy (EVT)

Indications 1, 2:

  • Proximal anterior circulation large vessel occlusion (ICA, M1, proximal M2)
  • Standard window: within 6 hours of symptom onset
  • Extended window: up to 24 hours in selected patients with favorable CT perfusion or MRI diffusion/perfusion mismatch

Optimal technique (BADDASS approach) 1:

  • Use combined stent-retriever and aspiration technique
  • Deploy stent-retriever with two-thirds beyond thrombus
  • Apply dual aspiration through balloon guide catheter and distal access catheter during retrieval
  • Goal: first-pass complete reperfusion to minimize time-dependent injury

System considerations 1:

  • Activate neuro-interventional team in parallel with stroke team at CT scanner
  • Have standardized angiography tray (Brisk Recanalization Ischemic Stroke Kit) ready
  • Consider tenecteplase over alteplase for patients undergoing EVT (improved fibrin-specificity, longer half-life, single bolus administration) 1

Post-Alteplase Monitoring and Complications

Neurological monitoring 1, 3:

  • Assess every 15 minutes during and for 2 hours after infusion
  • Every 30 minutes for next 6 hours
  • Hourly until 24 hours
  • If severe headache, acute hypertension, nausea, vomiting, or neurological worsening occurs: stop infusion immediately and obtain emergency head CT 1

Symptomatic intracranial hemorrhage management 1, 3:

  • Stop alteplase infusion
  • Obtain emergent non-contrast head CT
  • Check CBC, PT/INR, aPTT, fibrinogen, type and cross-match
  • Administer cryoprecipitate 10 units over 10-30 minutes (additional dose if fibrinogen <200 mg/dL)
  • Give tranexamic acid 1000 mg IV over 10 minutes OR ε-aminocaproic acid 4-5 g over 1 hour
  • Consult hematology and neurosurgery

Orolingual angioedema 1, 3:

  • Discontinue alteplase and hold ACE inhibitors
  • Maintain airway (awake fiberoptic intubation if needed)
  • Give IV methylprednisolone 125 mg
  • Give IV diphenhydramine 50 mg
  • Give ranitidine 50 mg IV or famotidine

Physiological Parameter Management

Temperature control 2, 3:

  • Monitor temperature every 4 hours for first 48 hours
  • Treat fever >37.5°C with antipyretics (acetaminophen)
  • Identify and treat sources of hyperthermia (infections)
  • Hypothermia only in clinical trial context

Glucose management 2, 3:

  • Monitor blood glucose regularly
  • Treat hyperglycemia to maintain 140-180 mg/dL
  • Avoid hypoglycemia with close monitoring

Avoid routine interventions 1:

  • Delay nasogastric tubes, indwelling bladder catheters, or intra-arterial pressure catheters for 24 hours if patient can be safely managed without them

Early Antiplatelet Therapy

  • Start aspirin 160-325 mg within 24-48 hours after ruling out hemorrhage on follow-up imaging 2, 3, 4
  • If alteplase was given, wait 24 hours before starting aspirin 3
  • Do NOT use urgent anticoagulation (IV heparin) for unselected acute ischemic stroke patients—hemorrhage risks exceed benefits 3, 4

Stroke Unit Care and Early Rehabilitation

  • Admit all stroke patients to a geographically defined stroke unit with specialized staff within 24 hours of arrival (reduces mortality OR 0.76 and dependency OR 0.80) 2
  • Begin rehabilitation assessment within 48 hours of admission 2
  • Start frequent, brief out-of-bed activity (active sitting, standing, walking) within 24 hours if no contraindications 2
  • Screen swallowing, nutrition, and hydration status on day of admission; provide alternative feeding (NG, ND, or PEG) if unable to take oral intake safely 2

Management of Cerebral Edema and Increased ICP

  • Do NOT use corticosteroids for cerebral edema 2
  • Use osmotherapy and hyperventilation for deteriorating patients 2
  • For large cerebellar infarctions with brainstem compression: surgical decompression may be life-saving 2
  • For malignant MCA infarction: proceed urgently to decompressive hemicraniectomy before significant GCS decline or pupillary changes, ideally within 48 hours of onset 3

Seizure Management

  • Treat new-onset seizures with short-acting medications (lorazepam IV) if not self-limiting 2
  • Do NOT use prophylactic anticonvulsants 2

Common Pitfalls to Avoid

  • Every 30-minute delay in recanalization decreases good functional outcome by 8-14%—speed is critical 2
  • Do not be overly restrictive with treatment criteria—current practice often extends beyond strict guideline recommendations based on individualized risk-benefit assessment 1
  • Failure to obtain follow-up imaging at 24 hours before starting antiplatelets or anticoagulants increases hemorrhage risk 1
  • Inadequate blood pressure control before thrombolysis significantly increases symptomatic ICH risk 1
  • Missing swallowing dysfunction leads to aspiration pneumonia—screen early 2
  • Delaying rehabilitation worsens functional outcomes—begin within 24-48 hours 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.